Inhibition of archaeal growth and DNA topoisomerase VI activities by the Hsp90 inhibitor radicicol

Nucleic Acids Research

Volumn 33, Issue 7, 2005, Pages 2310-2317

  Gadelle, D ^a   Bocs, C ^a   Graille, M ^a   Forterre, P ^b  

^a INSTITUTE FOR INTEGRATIVE BIOLOGY OF THE CELL I2BC   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE VI; GELDANAMYCIN; GYRASE INHIBITOR; HEAT SHOCK PROTEIN 90; RADICICOL; UNCLASSIFIED DRUG; BENZOQUINONE DERIVATIVE; ENZYME INHIBITOR; LACTONE; MACROCYCLIC LACTAM; MACROLIDE; QUINONE DERIVATIVE;

ARCHAEBACTERIUM; ARTICLE; BACTERIAL GROWTH; BINDING SITE; CONTROLLED STUDY; CRENARCHAEOTA; DRUG MECHANISM; DRUG RESISTANCE; ENZYME ACTIVITY; ESCHERICHIA COLI; EURYARCHAEOTA; GROWTH INHIBITION; HALOFERAX VOLCANII; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SULFOLOBUS; SULFOLOBUS ACIDOCALDARIUS; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY;

ARCHAEA; ESCHERICHIA COLI; HALOFERAX VOLCANII; SULFOLOBUS ACIDOCALDARIUS; SULFOLOBUS SHIBATAE;

BENZOQUINONES; CELL PROLIFERATION; DNA TOPOISOMERASES, TYPE II, ARCHAEAL; ENZYME INHIBITORS; HALOFERAX VOLCANII; HSP90 HEAT-SHOCK PROTEINS; LACTAMS, MACROCYCLIC; LACTONES; MACROLIDES; QUINONES; SULFOLOBUS ACIDOCALDARIUS;

EID: 17644388495     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gki526     Document Type: Article

References (34)

1. Wang,J.C. (1996) DNA topoisomerases. Annu. Rev. Biochem., 65, 635-692.
2. Champoux,J.J. (2001) DNA topoisomerases: Structure, function and mechanism. Annu. Rev. Biochem., 70, 369-413. Review.
3. Bergerat,A., de Massy,B., Gadelle,D., Varoutas,P.C., Nicolas,A. and Forterre,P. (1997) An atypical topoisomerase II from Archaea with implications for meiotic recombination. Nature, 386, 414-417.
4. Gadelle,D., Filee,J., Buhler,C. and Forterre,P. (2003) Phylogenomics of type II DNA topoisomerases. Bioessays, 25, 232-242.
5. Hartung,F. and Puchta,H. (2001) Molecular characterization of homologues of both subunits A (SPO11) and B of the archaebacterial topoisomerase 6 in plants. Gene, 271, 81-86.
6. Yin,Y., Cheong,H., Friedrichsen,D., Zhao,Y., Hu,J., Mora-Garcia,S. and Chory,J.A. (2002) Crucial role for the putative Arabidopsis topoisomerase VI in plant growth and development. Proc. Natl Acad. Sci., USA, 99, 10191-10196.
7. Mushegian,A.R., Bassett,D.E.Jr, Boguski,M.S., Bork,P. and Koonin,E.V. (1997) Positionally cloned human disease genes: Patterns of evolutionary conservation and functional motifs. Proc. Natl Acad. Sci., USA, 94, 5831-5836.
8. Dutta,R. and Inouye,M. (2000) GHKL, an emergent ATPase/kinase superfamily. Trends Biochem. Sci., 25, 24-28.
9. Corbett,K.D. and Berger,J.M. (2003) Structure of the topoisomerase VI-B subunit: Implications for type II topoisomerase mechanism and evolution. EMBO J., 22, 151-163.
10. Nichols,M.D., DeAngelis,K., Keek,J.L. and Berger,J.M. (1999) Structure and function of an archaeal topoisomerase VI subunit with homology to the meiotic recombination factor Spo11. EMBO J., 18, 6177-6188.
11. Buhler,C., Lebbink,J.H., Bocs,C., Ladenstein,R. and Forterre,P. (2001) DNA topoisomerase VI generates ATP-dependent double-strand breaks with two-nucleotide overhangs. J. Biol. Chem., 276, 37215-37222.
12. Maxwell,A. (1997) DNA gyrase as a drug target. Trends Microbiol., 5, 102-109.
13. Andoh,T. and Ishida,R. (1998) Catalytic inhibitors of DNA topoisomerase II. Biochim. Biophys. Acta., 1400, 155-171.
14. Larsen,A.K., Escargueil,A.E. and Skladanowski,A. (2003) Catalytic topoisomerase II inhibitors in cancer therapy. Pharmacol. Ther., 99, 167-181.
15. Bergerat,A., Gadelle,D. and Forterre,P. (1994) Purification of a DNA topoisomerase II from the hyperthermophilic archaeon Sulfolobus shibatae. A thermostable enzyme with both bacterial and eucaryal features. J. Biol. Chem., 269, 27663-27669.
16. Roe,S.M., Prodromou,C., O'Brien,R., Ladbury,J.E., Piper,P.W. and Pearl,L.H. (1999) Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J. Med. Chem., 42, 260-266.
17. Lopez-Garcia,P. and Forterre,P. (1997) DNA topology in hyperthermophilic archaea: Reference states and their variation with growth phase, growth temperature, and temperature stresses. Mol. Microbiol., 23, 1267-1279.
18. Allers,T., Ngo,H., Mevarech,M. and Lloyd,R.G. (2004) Development of additional selectable markers for the halophilic archaeon Haloferax volcanii based on the leuB and trpA genes. Appl. Environ. Microbiol., 70, 943-953.
19. Bilwes,A.M., Quezada,C.M., Croal,L.R., Crane,B.R. and Simon,M.I. (2001) Nucleotide binding by the histidine kinase CheA. Nature Struct. Biol., 8, 353-360.
20. Delmotte,P. and Delmotte-Plaque,J. (1953) A new antifungal substance of fungal origin. Nature, 171, 344.
21. Soga,S., Neckers,L.M., Schulte,T.W., Shiotsu,Y., Akasaka,K., Narumi,H., Agatsuma,T., Ikuina,Y., Murakata,C., Tamaoki,T. and Akinaga,S. (1999) KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules. Cancer Res., 59, 2931-2938.
22. Schulte,T.W., Akinaga,S., Soga,S., Sullivan,W., Stensgard,B., Toft,D. and Neckers,L.M. (1998) Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin. Cell Stress Chaperones, 3, 100-108.
23. Stebbins,C.E., Russo,A.A., Schneider,C., Rosen,N., Hartl,F.U. and Pavletich,N.P. (1997) Crystal structure of an Hsp90-geldanamycin complex: Targeting of a protein chaperone by an antitumor agent. Cell, 89, 239-250.
24. Prodromou,C., Roe,S.M., O'Brien,R., Ladbury,J.E., Piper,P.W. and Pearl,L.H. (1997) Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell, 90, 65-75.
25. Yang,W. (2002) Histidine kinases: Extended relationships with GHL ATPases. In Masayori Inouye and Rinku Dutta (eds), Histidine Kinases in Signal Transduction. Academic Press, New York, pp. 219-236.
26. Hu,X., Machius,M. and Yang,W. (2003) Monovalent cation dependence and preference of GHKL ATPases and kinases. FEBS Lett., 544, 268-273.
27. Besant,P.G., Lasker,M.V., Bui,C.D. and Turck,C.W. (2002) Inhibition of branched-chain alpha-keto acid dehydrogenase kinase and Sln1 yeast histidine kinase by the antifungal antibiotic radicicol. Mol. Pharmacol., 62, 289-296.
28. Lamour,V., Hoermann,L., Jeltsch,J.M., Oudet,P. and Moras,D. (2002) An open conformation of the Thermus thermophilus gyrase B ATP-binding domain. J. Biol. Chem., 277, 18947-18953.
29. Lewis,R.J., Singh,O.M., Smith,C.V., Skarzynski,T., Maxwell,A., Wonacott,A.J. and Wigley,D.B. (1996) The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography. EMBO J., 15, 1412-1420.
30. Sioud,M., Baldacci,G., de Recondo,A.M. and Forterre,P. (1988) Inhibitors of DNA topoisomerase II induce topological changes in an archaebacterial plasmid in vivo. Biochem. Pharmacol., 37, 1879-1880.
31. Holmes,M.L. and Dyall-Smith,M.L. (1991) Mutations in DNA gyrase result in novobiocin resistance in halophilic archaebacteria. J. Bacteriol., 173, 642-648.
32. Espeli,O., Lee,C. and Marians,K.J. (2003) A physical and functional interaction between Escherichia coli FtsK and topoisomerase IV. J. Biol. Chem., 278, 44639-44644.
33. Hartung,F., Angelis,K.J., Meister,A., Schubert,I., Melzer,M. and Puchta,H. (2002) An archaebacterial topoisomerase homolog not present in other eukaryotes is indispensable for cell proliferation of plants. Curr. Biol., 12, 1787-1791.
34. Sugimoto-Shirasu,K., Stacey,N.J., Corsar,J., Roberts,K. and McCann,M.C. (2002) DNA topoisomerase VI is essential for endoreduplication in Arabidopsis. Curr. Biol., 12, 1782-1786.